Jing Ji
Directeur Technique/Scientifique/R&D chez ABBISKO CAYMAN LIMITED
Postes actifs de Jing Ji
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABBISKO CAYMAN LIMITED | Directeur Technique/Scientifique/R&D | 01/02/2021 | - |
Historique de carrière de Jing Ji
Anciens postes connus de Jing Ji
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Directeur Technique/Scientifique/R&D | 01/05/2020 | 01/01/2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2015 | 01/05/2020 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/06/2006 | 01/01/2010 |
| Sanofi SA | Corporate Officer/Principal | 01/09/2003 | 01/09/2005 |
| Merck Sharp & Dohme (China) Ltd. | Corporate Officer/Principal | 01/12/1997 | 01/03/2003 |
Formation de Jing Ji
| Fudan University | Undergraduate Degree |
| Shanghai Second Medical University | Graduate Degree |
Statistiques
Internationale
| Chine | 5 |
| Royaume-Uni | 3 |
| Îles Cayman | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ABBISKO CAYMAN LIMITED | Health Technology |
| GSK PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Merck Sharp & Dohme (China) Ltd. | |
| Sanofi SA | Health Technology |
Shanghai Lianbio Development Co., Ltd.
Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Health Technology |
